HK1045262B - Gardos通道拮抗劑 - Google Patents

Gardos通道拮抗劑 Download PDF

Info

Publication number
HK1045262B
HK1045262B HK02106773.8A HK02106773A HK1045262B HK 1045262 B HK1045262 B HK 1045262B HK 02106773 A HK02106773 A HK 02106773A HK 1045262 B HK1045262 B HK 1045262B
Authority
HK
Hong Kong
Prior art keywords
compound
substituent
compounds
ring
acetamide
Prior art date
Application number
HK02106773.8A
Other languages
English (en)
Chinese (zh)
Other versions
HK1045262A1 (en
Inventor
G‧A‧麦克诺顿-史密斯
G‧A‧麥克諾頓-史密斯
G‧C‧里格登
J‧W‧施特克尔
J‧W‧施特克爾
Original Assignee
安克进药物公司
安克進藥物公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 安克进药物公司, 安克進藥物公司 filed Critical 安克进药物公司
Publication of HK1045262A1 publication Critical patent/HK1045262A1/xx
Publication of HK1045262B publication Critical patent/HK1045262B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/11—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK02106773.8A 1999-02-23 2000-02-10 Gardos通道拮抗劑 HK1045262B (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13551199P 1999-02-23 1999-02-23
US09/386,601 1999-08-31
US09/386,601 US6288122B1 (en) 1999-02-23 1999-08-31 Gardos channel antagonists
PCT/US2000/003663 WO2000050026A1 (en) 1999-02-23 2000-02-10 Gardos channel antagonists

Publications (2)

Publication Number Publication Date
HK1045262A1 HK1045262A1 (en) 2002-11-22
HK1045262B true HK1045262B (zh) 2005-07-29

Family

ID=26833406

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02106773.8A HK1045262B (zh) 1999-02-23 2000-02-10 Gardos通道拮抗劑

Country Status (16)

Country Link
US (1) US6288122B1 (enExample)
EP (1) EP1158971B1 (enExample)
JP (2) JP4038337B2 (enExample)
KR (1) KR100705726B1 (enExample)
CN (1) CN1193748C (enExample)
AP (1) AP1465A (enExample)
AT (1) ATE370728T1 (enExample)
AU (1) AU762039B2 (enExample)
BR (1) BR0008416A (enExample)
CA (1) CA2371857C (enExample)
DE (1) DE60036093T2 (enExample)
ES (1) ES2291191T3 (enExample)
HK (1) HK1045262B (enExample)
IL (2) IL145012A0 (enExample)
OA (1) OA11838A (enExample)
WO (1) WO2000050026A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003004010A1 (en) * 2001-07-06 2003-01-16 Poseidon Pharmaceuticals A/S Carbonylamino derivatives useful for obtaining immune regulation
EP1465863B1 (en) 2002-01-04 2008-07-09 NeuroSearch A/S Potassium channel modulators
AU2003217810C9 (en) * 2002-02-28 2008-06-12 Icagen, Inc. Methods for treating diseases related to intraocular pressure
EP1644332A1 (en) * 2003-07-03 2006-04-12 Poseidon Pharmaceuticals A/S Diarylmethyl derivatives as potassium channel modulators
WO2005003143A1 (en) * 2003-07-03 2005-01-13 Poseidon Pharmaceuticals A/S Novel potassium channel modulators
WO2006084031A1 (en) * 2005-02-01 2006-08-10 Icagen, Inc. Imines as ion channel modulators
US20100056637A1 (en) * 2005-12-20 2010-03-04 Icagen, Inc. Treatment methods using triaryl methane compounds
CA2633805A1 (en) * 2005-12-20 2007-07-05 Icagen, Inc. Treatment methods using triaryl methane compounds
WO2009027292A1 (en) * 2007-08-24 2009-03-05 Neurosearch A/S Carbonylamino derivatives useful for the treatment of certain inflammatory disorders
US20090076157A1 (en) * 2007-09-15 2009-03-19 Protia, Llc Deuterium-enriched senicapoc
KR101896430B1 (ko) * 2008-04-09 2018-09-10 세루스 코포레이션 적혈구 병원체 불활성화를 위한 개선된 퀀칭 방법
CN102272152B (zh) 2008-11-10 2014-05-28 贝林格尔.英格海姆国际有限公司 通过中电导钙激活钾通道调控细胞-细胞融合的组合物及方法
WO2016134353A1 (en) * 2015-02-20 2016-08-25 Children's Medical Center Corporation Methods for treating malaria using potassium channel inhibitors
EP3106155A1 (en) * 2015-06-15 2016-12-21 Universite d'Aix Marseille Treatment and diagnosis of hereditary xerocytosis
CN110177548A (zh) * 2016-10-25 2019-08-27 罗兰·斯塔尔 Senicapoc用于治疗神经性疼痛的用途
WO2018162426A1 (en) 2017-03-06 2018-09-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Treatment and diagnosis of hereditary xerocytosis
CN112020353A (zh) 2019-03-29 2020-12-01 深圳仁泰医药科技有限公司 2,2-双(4-氟苯基)-2-苯乙酰胺的晶型a及其制备方法和应用
US12186286B2 (en) * 2019-07-29 2025-01-07 Paracelsus Neuroscience Llc Use of senicapoc for treatment of stroke
CN115943138A (zh) * 2020-07-14 2023-04-07 阿迪玛生物有限责任公司 包含gardos通道拮抗剂的组合物及其用途
US20240024335A1 (en) * 2020-12-11 2024-01-25 Sanquin IP B.V. Treatment and prevention of anaemia of inflammation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273992A (en) 1992-11-02 1993-12-28 Beth Israel Hospital Assoc. Inc. Method for reducing sickle erythrocyte dehydration and delaying the occurrence of erythrocyte sickling in-situ
ATE314060T1 (de) 1996-03-20 2006-01-15 Harvard College Triarylmethanverbindungen zur behandlung von krebs, aktinischer keratose und kaposisarkom

Also Published As

Publication number Publication date
AU2880700A (en) 2000-09-14
AP1465A (en) 2005-09-22
AU762039B2 (en) 2003-06-19
JP4038337B2 (ja) 2008-01-23
CA2371857A1 (en) 2000-08-31
KR20020002393A (ko) 2002-01-09
JP2007262075A (ja) 2007-10-11
OA11838A (en) 2005-08-22
CA2371857C (en) 2008-07-29
IL145012A0 (en) 2002-06-30
KR100705726B1 (ko) 2007-04-11
ATE370728T1 (de) 2007-09-15
EP1158971A1 (en) 2001-12-05
WO2000050026A1 (en) 2000-08-31
CN1344158A (zh) 2002-04-10
BR0008416A (pt) 2002-01-29
AP2001002268A0 (en) 2001-09-30
DE60036093D1 (de) 2007-10-04
ES2291191T3 (es) 2008-03-01
DE60036093T2 (de) 2008-05-15
US6288122B1 (en) 2001-09-11
EP1158971B1 (en) 2007-08-22
HK1045262A1 (en) 2002-11-22
IL145012A (en) 2006-12-10
JP2002537331A (ja) 2002-11-05
CN1193748C (zh) 2005-03-23
EP1158971A4 (en) 2003-04-16

Similar Documents

Publication Publication Date Title
CN1193748C (zh) Gardos通道拮抗剂
CN85107020A (zh) 烷基亚磺酰胺基苯基烷基胺的制备方法
CN1255136A (zh) 取代的4－芳基亚甲基－2－亚氨基－2,3－二氢噻唑和衍生物及其药学应用
CN1261877A (zh) 4－溴或4－碘苯基氨基苯氧肟酸衍生物及其作为mek抑制剂的用途
CN1791576A (zh) 代谢型谷氨酸受体的苯甲酰胺调节剂
CN1589264A (zh) 用于治疗恶性肿瘤的方法
CN1033043A (zh) 新的抗抑郁剂的制法
CN1072927A (zh) 新的n-羟烷基取代的1，2，3，6-四氢吡啶和哌啶衍生物
CN1023402C (zh) 制备5-羟色胺拮抗药的方法
CN87100686A (zh) 用作心血管剂的3-烷氧基-2-氨基丙胺类化合物
CN1126990A (zh) 新的(1-苯基-1-杂环基)烷烃衍生物和作为神经保护剂的应用
CN1014515B (zh) 制备mao抑制剂—非芳香族氟烯丙胺的方法
CN1960974A (zh) 烷基取代的哌啶衍生物及其作为单胺神经递质再摄取抑制剂的用途
CN1015175B (zh) 苯甲酰胺类抗惊厥剂的制备方法
CN1091632A (zh) 药剂
CN1177852C (zh) 膦酸二酯衍生物
CN1914169A (zh) 作为环氧合酶－2抑制剂的二芳基－2－(5h)－呋喃酮的氧化氮释放前药
CN1466573A (zh) 5-苯基苄胺化合物、其制备方法以及其合成中间体
CN88103114A (zh) 杂环化合物
CN1249018C (zh) 用于镰状细胞疾病的三芳基甲烷化合物
CN1232388A (zh) 抗疟疾和抗巴贝虫病剂和含有它们的药物组合物
CN1306422A (zh) 用于治疗或预防以异常细胞增殖为特征之疾病的经取代的二苯基茚满酮、茚满和吲哚化合物及其类似物
CN1034710A (zh) 新化合物
CN1170716A (zh) 双－邻位取代的苯甲酰胍、其制备方法、用途及含有它们的药物
CN88103112A (zh) 酰胺类化合物

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140210